Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.920
+0.020 (1.05%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 264.58% from the current stock price of 1.92.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for RMTI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +368.75% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +368.75% | Mar 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +472.92% | Nov 15, 2023 |
Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +160.42% | Oct 5, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +472.92% | Oct 4, 2023 |
Financial Forecast
Revenue This Year
94.34M
from 83.61M
Increased by 12.83%
Revenue Next Year
104.66M
from 94.34M
Increased by 10.94%
EPS This Year
-0.14
from -0.37
EPS Next Year
0.03
from -0.14
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 97.8M | 111.4M |
Avg | 94.3M | 104.7M |
Low | 90.0M | 97.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 17.0% | 18.0% |
Avg | 12.8% | 10.9% |
Low | 7.6% | 3.0% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.14 | 0.04 |
Avg | -0.14 | 0.03 |
Low | -0.14 | 0.01 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.